Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Merck NYSE:MRK |
297,40 Mrd. | 7,67 % | 6/6 | -21,36 % | -10,44 % | 9,73 % | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.025,14 Mrd. | 20,54 % | 5/6 | -8,58 % | 67,73 % | 30,36 % | DOWN |
|
Pfizer NYSE:PFE |
159,73 Mrd. | 7,82 % | 4/6 | -5,31 % | 18,85 % | -3,85 % | UP |
|
Bristol-Myers Squibb NYSE:BMY |
123,83 Mrd. | 1,77 % | 5/6 | -0,30 % | -4,27 % | 5,52 % | UP |
|
Sanofi ENXTPA:SAN |
99,89 Mrd. | 5,21 % | 5/6 | 7,19 % | 13,59 % | 20,89 % | DOWN |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
113,44 Mrd. | 13,44 % | 6/6 | 6,43 % | -3,52 % | 24,96 % | DOWN |
|
Takeda Pharmaceutical Company TSE:4502 |
8.948,06 Mrd. | 10,31 % | 3/5 | 22,10 % | -30,48 % | 2,40 % | UP |
|
Incyte NasdaqGS:INCY |
18,74 Mrd. | 41,79 % | 5/6 | 8,74 % | 28,31 % | 13,12 % | UP |
|
Ionis Pharmaceuticals NasdaqGS:IONS |
12,40 Mrd. | 2,79 % | 2/6 | -10,93 % | -188,06 % | 33,17 % | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,86 Mrd. | 12,22 % | 5/6 | 45,50 % | 58,53 % | 66,40 % | DOWN |
|
PTC Therapeutics NasdaqGS:PTCT |
5,64 Mrd. | 31,02 % | 5/6 | -43,33 % | -71,21 % | 23,29 % | UP |
|
CRISPR Therapeutics NasdaqGM:CRSP |
4,57 Mrd. | 30,82 % | 2/6 | 1267,38 % | 54,59 % | 68,17 % | DOWN |
|
Agios Pharmaceuticals NasdaqGS:AGIO |
1,98 Mrd. | -20,51 % | 2/6 | 69,17 % | -56,85 % | 22,67 % | DOWN |
|
Geron NasdaqGS:GERN |
0,95 Mrd. | 225,94 % | 3/5 | 18,44 % | 99,16 % | 168,46 % | DOWN |
|
Fulcrum Therapeutics NasdaqGM:FULC |
0,51 Mrd. | 0,00 % | 1/4 | 0,00 % | 0,00 % | 180,31 % | DOWN |
|
Silence Therapeutics NasdaqGM:SLN |
0,25 Mrd. | 46,48 % | 2/6 | -87,89 % | 54,93 % | 374,38 % | DOWN |
|
Emmaus Life Sciences OTCPK:EMMA |
0,00 Mrd. | -11,68 % | 2/4 | 0,00 % | 0,00 % | -100,00 % | UP |
